These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30267759)

  • 1. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis.
    Hussain A; Rather MA; Bhat ZS; Majeed A; Maqbool M; Shah AM; Aga MA; Shah A; Mushtaq S; Sangwan PL; Hassan QP; Ahmad Z
    Int J Antimicrob Agents; 2019 Jan; 53(1):49-53. PubMed ID: 30267759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptomyces puniceus strain AS13., Production, characterization and evaluation of bioactive metabolites: A new face of dinactin as an antitumor antibiotic.
    Hussain A; Rather MA; Dar MS; Dangroo NA; Aga MA; Qayum A; Shah AM; Ahmad Z; Dar MJ; Hassan QP
    Microbiol Res; 2018 Mar; 207():196-202. PubMed ID: 29458855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro bactericidal activity of 3-cinnamoyl-4-hydroxy-6-methyl-2-pyrone (CHP) against drug-susceptible, drug-resistant and drug-tolerant isolates of Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Ul Lah H; Hussain A; Maqbool M; Yousuf SK; Jabeen Z; Wani MA; Ahmad Z
    J Glob Antimicrob Resist; 2020 Sep; 22():57-62. PubMed ID: 31809940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
    Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
    Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
    Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
    Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
    Bax HI; de Steenwinkel JE; Ten Kate MT; van der Meijden A; Verbon A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2015 Oct; 70(10):2828-37. PubMed ID: 26183185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
    Gonzalo X; Casali N; Broda A; Pardieu C; Drobniewski F
    Int J Antimicrob Agents; 2015 Apr; 45(4):406-12. PubMed ID: 25717028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
    Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
    Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis.
    Islam MI; Han CM; Seo H; Kim S; Mahmud HA; Nam KW; Lee BE; Sadu VS; Lee KI; Song HY
    Int J Antimicrob Agents; 2019 Jul; 54(1):69-74. PubMed ID: 30807817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of minimum bactericidal concentration, in single or combination drugs, against
    Santos NCS; Scodro RBL; Leal DC; do Prado SM; Micheletti DF; Sampiron EG; Costacurta GF; de Almeida AL; da Silva LA; Ieque AL; Ghiraldi Lopes LD; de Pádua RA; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF
    Future Microbiol; 2020 Jan; 15():107-114. PubMed ID: 32064924
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.
    Rey-Jurado E; Tudó G; de la Bellacasa JP; Espasa M; González-Martín J
    Int J Antimicrob Agents; 2013 Mar; 41(3):278-80. PubMed ID: 23312604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G
    J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Small-Molecule Inhibitor of the
    Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
    mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.